BONUSCAP-ZERTIFIKAT - CARL ZEISS MEDITEC Stock

Certificat

DE000HD27JH3

Market Closed - BOERSE MUENCHEN 03:45:11 2024-05-31 pm EDT
122 EUR -6.46% Intraday chart for BONUSCAP-ZERTIFIKAT - CARL ZEISS MEDITEC
Current month-11.28%
1 month-11.28%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 122 -6.46%
24-05-30 130.4 +3.04%
24-05-29 126.6 -2.81%
24-05-28 130.2 -3.57%
24-05-27 135 -0.49%

Real-time BOERSE MUENCHEN

Last update May 31, 2024 at 03:45 pm EDT

More quotes

Static data

Product typeBonus- und Teilschutz-Zertifikate
Buy / SellCALL
Underlying CARL ZEISS MEDITEC AG
IssuerLogo Issuer UniCredit UniCredit
WKN HD27JH
ISINDE000HD27JH3
Date issued 2024-01-26
Strike 150
Maturity 2024-09-20 (112 Days)
Parity 1 : 1
Emission price 130.7
Emission volume N/A
Settlement Beides
Currency EUR

Technical Indicators

Highest since issue 146.1
Lowest since issue 120.2
Spread 0.53
Spread %0.43%

Company Profile

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
Sector
-
More about the company

Ratings for Carl Zeiss Meditec AG

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Carl Zeiss Meditec AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
84.65 EUR
Average target price
103.9 EUR
Spread / Average Target
+22.70%
Consensus